Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade：an Randomized Clinical Trial

NCT06080880 is registered in ClinicalTrials.gov with Hubei Cancer Hospital as lead sponsor.

NCT NCT06080880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06080880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade：an Randomized Clinical Trial
Lead sponsor
Hubei Cancer Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2023
Completion date
November 30, 2027
Enrollment
98 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nausea with vomiting chemotherapy-induced